SCHEMBL3200924

SCHEMBL3200924

O=C(O)C1C[CH][CH]CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455796 0.78
SCHEMBL1661673 0.78
SCHEMBL1663681 0.78
SCHEMBL1476768 0.76
SCHEMBL18576616 0.76
SCHEMBL15330936 0.76
Hydrochloric Acid SCHEMBL9143086 0.74 EGLN1 (0.45)
SCHEMBL27558661 0.65
SCHEMBL27907553 0.65
SCHEMBL242266 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 US claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US disclosed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 US disclosed
US-20140080140-A1 SCREENING FOR NEUROTOXIC AMINO ACID ASSOCIATED WITH NEUROLOGICAL DISORDERS THE INSTITUTE FOR ETHNOMEDICINE 2014-03-20 US disclosed
US-8541184-B2 Screening for neurotoxic amino acid associated with neurological disorders THE INSTITUTE FOR ETHNOMEDICINE (US) 2013-09-24 US disclosed
US-8383887-B2 Methods of using plants containing the gdhA gene SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) 2013-02-26 US disclosed
US-20100223693-A1 METHODS OF USING PLANTS CONTAINING THE GDHA GENE SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) 2010-09-02 US disclosed
US-7670783-B2 Screening for neurotoxic amino acid associated with neurological disorders THE INSTITUTE FOR ETHNOMEDICINE (US) 2010-03-02 US disclosed
US-4482725-A ANGIOTENSIN CONVERTING ENZYME INHIBITOR E. R. SQUIBB & SONS, INC. (US) 1984-11-13 US disclosed
EP-0022219-B1 5-OXO- AND 5-THIOXOPROLINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM E.R. Squibb &amp; Sons, Inc. (US) 1984-10-10 EP disclosed
US-4221912-A Dithio derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids E. R. SQUIBB & SONS, INC. (US) 1980-09-09 US disclosed
US-4217458-A Acylmercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids E. R. SQUIBB & SONS, INC. (US) 1980-08-12 US disclosed
US-4198515-A Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids E. R. SQUIBB & SONS, INC. (US) 1980-04-15 US disclosed
US-4156084-A Certain dimers of tetrahydropyridine-2-carboxylic acids or pyrroline-2-carboxylic acids and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1979-05-22 US disclosed
US-4154942-A Certain tetrahydropyridine-2-carboxylic acids and pyrroline-2-carboxylic acids and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed
US-4129566-A Derivatives of dehydrocyclicimino acids E. R. SQUIBB & SONS, INC. (US) 1978-12-12 US disclosed